MLL5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.082200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.238400E-01
Normal-vs-Stage2
2.325800E-01
Normal-vs-Stage3
1.051180E-01
Normal-vs-Stage4
5.284400E-01
Stage1-vs-Stage2
9.838600E-01
Stage1-vs-Stage3
1.026380E-01
Stage1-vs-Stage4
1.771770E-02
Stage2-vs-Stage3
2.094600E-01
Stage2-vs-Stage4
1.882490E-02
Stage3-vs-Stage4
1.223600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.790250E-01
Normal-vs-AfricanAmerican
6.431600E-01
Normal-vs-Asian
3.296000E-01
Caucasian-vs-AfricanAmerican
4.071400E-01
Caucasian-vs-Asian
8.024200E-01
AfricanAmerican-vs-Asian
5.330200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.226600E-01
Normal-vs-Female
2.104200E-01
Male-vs-Female
9.893200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.000800E-01
Normal-vs-Age(41-60Yrs)
5.038000E-01
Normal-vs-Age(61-80Yrs)
1.483760E-01
Normal-vs-Age(81-100Yrs)
3.310000E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.570000E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.801240E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.742300E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.820300E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.141100E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.663240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.377620E-01
Normal-vs-Daily Drinker
1.011000E-01
Normal-vs-Weekly Drinker
3.625800E-01
Normal-vs-Occasional Drinker
2.935400E-01
Normal-vs-Social Drinker
2.558800E-01
Non Drinker-vs-Daily Drinker
5.091000E-01
Non Drinker-vs-Weekly Drinker
7.358600E-01
Non Drinker-vs-Occasional Drinker
3.037400E-01
Non Drinker-vs-Social Drinker
3.228200E-01
Daily Drinker-vs-Weekly Drinker
4.410000E-01
Daily Drinker-vs-Occasional Drinker
1.267400E-01
Daily Drinker-vs-Social Drinker
1.376160E-01
Weekly Drinker-vs-Occasional Drinker
6.672400E-01
Weekly Drinker-vs-Social Drinker
6.810400E-01
Occasional Drinker-vs-Social Drinker
9.905800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.814100E-02
Normal-vs-Grade 2
7.626700E-04
Normal-vs-Grade 3
7.539000E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.224250E-01
Grade 1-vs-Grade 3
2.336600E-01
Grade 1-vs-Grade 4
3.814100E-02
Grade 2-vs-Grade 3
7.465200E-01
Grade 2-vs-Grade 4
7.626700E-04
Grade 3-vs-Grade 4
7.539000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.441400E-01
Normal-vs-NonDiabetic
1.511000E-01
Diabetic-vs-NonDiabetic
9.408000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.302800E-01
Normal-vs-NoPancreatitis
1.779370E-01
Pancreatitis-vs-NoPancreatitis
8.832000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.053200E-01
Normal-vs-N1
2.297600E-01
N0-vs-N1
5.382200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.585800E-01
Normal-vs-TP53-NonMutant
3.686400E-01
TP53-Mutant-vs-TP53-NonMutant
7.613800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
